Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
85,635,017
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
63,434,614
-
Shares change
-
-759,868
-
Total reported value, excl. options
-
$245,492,888
-
Value change
-
-$5,894,960
-
Put/Call ratio
-
12%
-
Number of buys
-
57
-
Number of sells
-
59
-
Price
-
$3.87
Institutional Holders of Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) as of Q4 2024
As of 31 Dec 2024 Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) had 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 63,434,614 shares of stock of the company.
Largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., Blue Owl Capital Holdings LP, GOLDMAN SACHS GROUP INC, BlackRock, Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Driehaus Capital Management LLC, and Verition Fund Management LLC.
This table shows 115 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.